PACEMAKER MEDIATED TACHYCARDIA DETECTION AND INTERVENTION

    公开(公告)号:US20180117324A1

    公开(公告)日:2018-05-03

    申请号:US15499692

    申请日:2017-04-27

    Abstract: A method of employing an implantable medical device to detect pacemaker mediated tachycardia (PMT) and adjusting a parameter (e.g. PVARP) in response to confirmation of the PMT. The method comprises, with a processor located in the implantable medical device, (1) measuring a first Vp-As (VA1), (2) lengthening SAV by 50 ms for 1 beat in response to measuring VA1, (3) measuring a second Vp-As (VA2), (4) returning to a normal SAV, (5) measuring a third Vp-As (VA3), (6) determining whether VA1=VA2 and VA1=VA3, (7) in response to determining whether VA1=VA2 and VA1=VA3, confirming presence of PMT, and (8) in response to confirming presence of PMT, PVARP is extended.

    TETS coil alignment conditions algorithm

    公开(公告)号:US12138441B2

    公开(公告)日:2024-11-12

    申请号:US17163740

    申请日:2021-02-01

    Abstract: A TETS having an external controller having a power source, a transmission coil in communication with the external controller, a receiving coil configured for transcutaneous inductive communication with the transmission coil, and an implantable controller in communication with the receiving coil and an implantable blood pump. The implantable controller has a battery configured to receive power from the receiving coil and the external controller is configured to categorize power transfer states based on predetermined thresholds of efficiency and power demand, and user display states (associated with optional configurable notifications) based on the power transfer states and predetermined temperature thresholds of the transmission coil.

    IMPLANTABLE MEDICAL DEVICE WITH SYSTEM INTEGRITY DETERMINATION FOR EXPEDITED PATIENT DISCHARGE

    公开(公告)号:US20230191134A1

    公开(公告)日:2023-06-22

    申请号:US18062332

    申请日:2022-12-06

    CPC classification number: A61N1/3702 A61B5/0031

    Abstract: An implantable medical device (IMD) performs, within a first predetermined time following an implantation, a first device test sequence over an evaluation period. The device test sequence includes at least two of: detecting an impedance for at least one electrical path having at least one electrode, and comparing the impedance to a first predetermined impedance threshold to determine a connection status of the IMD; comparing, over an electrogram (EGM) test period, at least one EGM event of the patient against a first predetermined EGM event threshold; determining a first pacing capture threshold of the IMD; and detecting at least one clinical or patient-specific physiologic metric, and comparing the physiologic metric to a first predetermined physiologic metric threshold. The IMD transmits within a second predetermined time a status signal to an external device indicating a status of at least one of the diagnostic tests in the first device test sequence.

    LEAD IMPEDANCE MEASUREMENT FOR PHYSIOLOGICAL AND DEVICE MANAGEMENT

    公开(公告)号:US20230068078A1

    公开(公告)日:2023-03-02

    申请号:US17878557

    申请日:2022-08-01

    Abstract: An example system includes memory configured to store a plurality of lead impedances (LeadZs) and processing circuitry communicatively coupled to the memory. The processing circuitry is configured to determine a first sensed LeadZ, and determine a second sensed LeadZ. The processing circuitry is configured to determine a first difference between the first sensed LeadZ and the second sensed LeadZ, and determine a parameter based at least in part on the first difference. The first sensed LeadZ and the second sensed LeadZ are sensed during a same first cardiac cycle or adjacent cardiac cycles of a heart that is receiving pacing.

Patent Agency Ranking